Melanoma mortality following skin cancer screening in Germany

BMJ Open

Volumn 5, Issue 9, 2015, Pages

  Boniol, Mathieu ^a,b   Autier, Philippe ^a,b   Gandini, Sara ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CUTANEOUS MELANOMA; DATA BASE; DATA EXTRACTION; FEMALE; FOLLOW UP; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; POPULATION SIZE; SKIN CANCER; TREND STUDY; WORLD HEALTH ORGANIZATION; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; INCIDENCE; MASS SCREENING; MELANOMA; MORTALITY; PROCEDURES; PROGRAM EVALUATION; SKIN NEOPLASMS;

ADULT; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; PROGRAM EVALUATION; SKIN NEOPLASMS;

EID: 84947738114     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008158     Document Type: Article

References (20)

1. Lakhani NA, Saraiya M, Thompson TD, et al. Total body skin examination for skin cancer screening among US adults from 2000 to 2010. Prev Med 2014; 61: 75-80
2. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201-11
3. Waldmann A, Nolte S, Weinstock MA, et al. Skin cancer screening participation, and impact on melanoma incidence in Germany-an observational study on incidence trends in regions with, and without population-based screening. Br J Cancer 2012; 106: 970-4
4. Anders MP, Nolte S, Waldmann A, et al. The German SCREEN project-design, and evaluation of the communication strategy. Eur J Public Health 2015; 25: 150-5
5. Katalinic A, Waldmann A, Weinstock MA, et al. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with, and without screening. Cancer 2012; 118: 5395-402
6. Mayer JE, Swetter SM, Fu T, et al. Screening, early detection, education, and trends for melanoma: current status (2007-2013), and future directions: Part II. Screening, education, and future directions. J Am Acad Dermatol 2014; 71: 611.e1-10
7. Geller AC, Greinert R, Sinclair C, et al. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening, and Prevention (September 24, and 25, 2009). Cancer Epidemiol 2010; 34: 355-8
8. Eisemann N, Waldmann A, Garbe C, et al. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Med Decis Making 2015; 35: 243-54
9. Kornek T, Schäfer I, Reusch M, et al. Routine skin cancer screening in Germany: four years of experience from the dermatologists? perspective. Dermatology 2012; 225: 289-93
10. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (GEKID). http://www.gekid.de (accessed 10 Dec 2014
11. Gesundheitsberichterstattung des Bundes. www.gbe-bund.de (accessed 15 Dec 2014
12. National Cancer Institute. Joinpoint Regression Program, Version 3.5.4. Statistical Research, and Applications Branch, National Cancer Institute, August 2012
13. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51
14. Breitbart EW, Choudhury K, Anders MP, et al. Benefits, and risks of skin cancer screening. Oncol Res Treat 2014; 37(Suppl 3): 38-47
15. Debating Population vs. Genetic Screening for Melanoma. Oncology Times 2015; 37: 9-10
16. Etzioni R, Legler JM, Feuer EJ, et al. Cancer surveillance series: interpreting trends in prostate cancer-part III: quantifying the link between population prostate-specific antigen testing, and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999; 91: 1033-9
17. USSG. US Department of Health, and Human Services. The Surgeon General?s call to action to prevent skin cancer. Washington DC: US Dept of Health, and Human Services, Office of the Surgeon General, 2014. http://www.surgeongeneral.gov/library/calls/prevent-skin-cancer/(accessed 15 Dec 2014
18. Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol 2011; 11: 129
19. Das C. Death certificates in Germany, England, The Netherlands, Belgium, and the USA. Eur J Health Law 2005; 12: 193-211
20. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-2